Cargando…
Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
BACKGROUND: Cardiotoxicity is one of the most serious chronic complications of anthracyclines therapy. Assessment of the left ventricular ejection fraction (LVEF) fails to detect subtle cardiac dysfunction of left ventricular (LV). This study aimed to detect and evaluate new parameters of subclinica...
Autores principales: | Hu, Hui-Min, Zhang, Xiao-Lin, Zhang, Wei-Ling, Huang, Dong-Sheng, Du, Zhong-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6006810/ https://www.ncbi.nlm.nih.gov/pubmed/29893362 http://dx.doi.org/10.4103/0366-6999.233950 |
Ejemplares similares
-
Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
por: Choi, Hyoung Soo, et al.
Publicado: (2010) -
Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients
por: Zhou, Xi, et al.
Publicado: (2023) -
Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020) -
Study on influencing factors of anthracycline-induced subclinical cardiotoxicity in DLBCL patients administered (R)-CHOP
por: Dong, Qian, et al.
Publicado: (2022) -
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)